Histone deacetylases 1 and 2 (HDAC1/2) form the core catalytic components of corepressor complexes that modulate gene expression. In most cell types, deletion of both Hdac1 and Hdac2 is required to generate a discernible phenotype, suggesting their activity is largely redundant. We have therefore generated an ES cell line in which Hdac1 and Hdac2 can be inactivated simultaneously. Loss of HDAC1/2 resulted in a 60% reduction in total HDAC activity and a loss of cell viability. Cell death is dependent upon cell cycle progression, because differentiated, nonproliferating cells retain their viability. Furthermore, we observe increased mitotic defects, chromatin bridges, and micronuclei, suggesting HDAC1/2 are necessary for accurate chromosome segregation. Consistent with a critical role in the regulation of gene expression, microarray analysis of Hdac1/2-deleted cells reveals 1,708 differentially expressed genes. Significantly for the maintenance of stem cell self-renewal, we detected a reduction in the expression of the pluripotent transcription factors, Oct4, Nanog, Esrrb, and Rex1. HDAC1/2 activity is regulated through binding of an inositol tetraphosphate molecule (IP 4 ) sandwiched between the HDAC and its cognate corepressor. This raises the important question of whether IP 4 regulates the activity of the complex in cells. By rescuing the viability of double-knockout cells, we demonstrate for the first time (to our knowledge) that mutations that abolish IP 4 binding reduce the activity of HDAC1/2 in vivo. Our data indicate that HDAC1/2 have essential and pleiotropic roles in cellular proliferation and regulate stem cell self-renewal by maintaining expression of key pluripotent transcription factors.
H istone deacetylase 1 and 2 (HDAC1/2) are highly related enzymes (∼80% identical) that regulate chromatin structure as components of the multiprotein Sin3 (1, 2), NuRD (3), and CoREST (4) corepressor complexes. The recruitment and activity of HDAC1/2 within these multiprotein complexes was thought to be a constitutive process. However, it has recently been shown that the HDAC1/metastasis-associated 1 (MTA1) complex (of NuRD) is regulated by a molecule of inositol tetraphosphate [Ins(1,4,5,6)P 4 ] (IP 4 ), which regulates its enzymatic activity, presumably in response to external signaling pathways (5) . Because deacetylation of histone tails results in the tightening of nucleosomal arrays (6) , the physiological roles of HDAC1/2 have mostly been defined within the context of transcriptional repression. However, genome-wide mapping of HDAC1 target genes reveals a correlation between binding and transcriptional activity (7, 8) , suggesting that HDAC1/2 may play a role in the cyclical acetylation of histones at active promoters (9) . HDAC1/2 may thus have roles in both transcriptional activation and repression.
Although there are a burgeoning number of proteins in the acetylome in addition to histones (10) , the Sin3A, NuRD, and CoREST complexes contain multiple DNA/chromatin recognition motifs (11) , which, in combination with transcription factors (2, 12) , target HDAC1/2 to chromatin. Their physiological roles should therefore be viewed within the framework of chromatin modulation. In the process of DNA double-strand break repair, for instance, they deacetylate histones in the vicinity of the lesion, which is a critical step in nonhomologous end joining (13) . During DNA replication, new histones are deposited in an acetylated form before being rapidly deacetylated as the chromatin matures (14) . A recent study that used the isolation of proteins on nascent DNA (iPOND) technique, found that HDAC1/2 are recruited close to the replication fork (15) , which suggests that they play a role in the maturation of chromatin during S phase. Successful mitosis also requires appropriate patterns of histone acetylation. The Sin3A complex helps maintain pericentric heterochromatin in a hypoacetylated state to ensure correct assembly of the kinetochore and faithful chromosome segregation (16, 17) . HDAC1/2 are likely to be expressed in most, if not all, mammalian cells. A generic requirement for HDAC1/2 in cell cycle progression makes them potentially useful therapeutic targets in the treatment of cancer, because blocking their activity with small-molecule inhibitors should limit cellular proliferation (11) .
With a few significant exceptions [embryogenesis (18) , heart (19) , and brain (20) ], the physiological activities of HDAC1 and HDAC2 are functionally redundant. Conditional deletion of Significance Histone deacetylase 1 and 2 (HDAC1/2) are sister proteins that regulate access to DNA by modulating chromatin. We have generated the first double knockout (DKO) of Hdac1/2 in embryonic stem (ES) cells and find that gene inactivation causes a loss of cell viability, which is associated with increased abnormal mitotic spindles and chromosome segregation defects. Transcriptome analysis revealed that almost 2,000 genes are deregulated in DKO cells. Significantly for the self-renewal properties of ES cells, this includes down-regulation of the core pluripotent factors, Oct4, Nanog, and Rex1. Furthermore, using the rescue of Hdac1/2-null cells as a model system to monitor HDAC1/2 activity, we have also shown that mutations that abolish inositol tetraphosphate binding reduce the activity of HDAC1 in vivo.
Hdac1 or Hdac2 alone, using tissue-specific transgenic models, produced no obvious deleterious effects on the development of heart, smooth muscle, endothelial cells, neural crest cells (19) , oocytes (21) , epidermis (22) , B cells (23) , and T cells (24) ; whereas simultaneous deletion of Hdac1/2 in these same cell types produced a number of profound phenotypes [summarized in Kelly and Cowley (11) ]. We recently described the generation and characterization of conditional knockout embryonic stem (ES) cells for Hdac1 or Hdac2 (25) . Although their differentiation properties are altered, cell viability and pluripotent potential of ES cells were unaffected by loss of either HDAC1 or HDAC2 alone. To circumvent this functional redundancy, we have engineered a double conditional knockout (DKO) (HDAC1 Lox/Lox ; HDAC2 Lox/Lox ; CreER) cell line, in which we can inactivate both genes simultaneously using a tamoxifen-inducible Cre/estrogen receptor fusion expressed from the ROSA26 locus. We demonstrate that loss of HDAC1/2 causes loss of cell viability 4 days following gene inactivation, which is associated with an increase in abnormal mitotic spindles and chromosome segregation defects. Almost 2,000 genes are deregulated. Significantly for the self-renewal properties of ES cells, this includes down-regulation of the core pluripotent factors, Oct4, Nanog, and Rex1. Furthermore, using the rescue of Hdac1/2-null cells as a model system to monitor HDAC1/2 activity, we have also shown for the first time (to our knowledge) that mutations that abolish IP 4 binding reduce the activity of HDAC1 in vivo. (Fig. 1A) , using standard gene targeting methodology. Induction of CreER, using 4-hydroxytamoxifen (OHT), causes deletion of exon 2 and disrupts the ORF such that a premature stop codon is introduced in exon 3. Consistent with our previous data (25) , inactivation of the Hdac1 and Hdac2 genes resulted in loss of each protein 2-3 days after OHT treatment (Fig.  1B) , indicating that both proteins have a half-life of ∼24 h (Fig. S1 ). The total deacetylase activity of the cell decreases by 60% over this same period (Fig. 1C) , indicating that HDAC1/2 are, biochemically at least, the predominant HDAC enzymes in the cell. At 3 days following OHT treatment, Hdac1/2-deleted ES cells showed a change in morphology (Fig. S2A ) and a subtle increase in cell death (2-11% sub-G 1 cells; Fig. 1D ). We also observed a slight reduction in the percentage of S-phase cells (60% vs. 48% 5-ethynyl-2′-deoxyuridine incorporation) in DKO cells compared with controls (Fig. S1C) . However, at 4 days there was a profound loss of cell viability (2-75% sub-G 1 cells). When we monitored the growth of DKO and control cells, it was observed that DKO cells fail to proliferate beyond day 2 when HDAC1/2 levels are <20% of wild type (Fig. S1 ). However, when we first stimulate cell cycle exit before deletion, by making embryoid bodies (Fig. 1F ) or using retinoic acid treatment (Fig. S1B) , the majority of cells remained viable, implying that the lethal phenotype is cell cycle dependent.
Results

Inactivation of
To search for potential cell cycle defects in Hdac1/2-deleted cells, we stained control (DKO cells, day 0), individual Hdac1 and Hdac2 knockout cells (25) , a compound Hdac1-KO; Hdac2-Het knockout cell line (Fig. S1D) , and DKO cells at day 3 after deletion, with anti-α-tubulin, anti-γ-tubulin and Hoechst 33258 to visualize chromosomes during the various stages of cell division. Initially, we focused on mitotic cells because experiments in mouse embryo fibroblasts (16) and Schizosaccharomyces pombe (17) have shown a role for the Sin3A complex in chromosome segregation. In contrast to individual and compound knockouts, a high proportion of the DKO cells in metaphase had a monopolar rather than a bipolar mitotic spindle ( Fig. 2A and Fig. S2B ). Consistent with this result, we also observed a sixfold increase in the number of DKO cells with segregation defects (Fig. 2B and Fig. S2C ; quantified in Fig. 2C ), including both lagging chromosomes and chromatin bridges, suggesting the presence of both premitotic and mitotic errors. Interphase cells also displayed a significant increase in micronucleation, multinucleate cells, and cells with lobed or highly condensed chromatin (summarized as DNA abnormalities; Fig. 2C and Fig. S2D) . We conclude, then, that a double deletion of Hdac1/2 results in severe chromosome segregation defects and that this is likely a major cause of cell death in DKO cells.
Loss of HDAC1/2 Disrupts Corepressor Complex Integrity and Leads to
an Increase in Global Histone Acetylation. HDAC1/2 are recruited into three main transcriptional corepressor complexes: Sin3A (26), NuRD (3), and CoREST (4). Incorporation into specific complexes is fundamental to HDAC function because they do not bind DNA directly and they tend to be active only in the presence of a binding partner, often a cognate corepressor protein, such as MTA2 (27) . To test the integrity of HDAC1/2-containing complexes, we performed Western blots on protein extracts from control and day 3 DKO cells ( Fig. 3A) . Upon simultaneous deletion of Hdac1/2, we observed a 4.2-and 7.1-fold decrease in the levels of Sin3A and MTA2, respectively, direct binding partners of HDAC1/2 (Fig. 3A) . The level of SDS3, an essential gene that facilitates the interaction of Sin3A/HDAC1 (16, 28) , is also reduced 2.6-fold relative to controls (Fig. 3A and  Fig. S3A ). However, the expression level of HDAC3, a highly related class I HDAC that forms part of the SMRT/NCoR complex, is increased sevenfold (Fig. 3B and Fig. S3B ), which suggests a partial compensation for the loss of HDAC1/2. These data suggest that HDAC1/2 contribute to the structural integrity of the Sin3A and NuRD complexes. The interaction of HDAC1/2 with the NuRD complex is mediated through the ELM2-SANT domains of the MTA family, MTA1-3 (5, 29). The ELM2-SANT region of MTA1 wraps completely around the catalytic domain of HDAC1 making extensive protein-protein contacts (Fig. 3C) . Importantly, the conserved N-terminal region of ELM2 (residues 162-198), which binds an extended groove on the side of HDAC1, lacks extensive secondary structure. In the absence of HDAC1/2, this region is likely to be solvent exposed and therefore lead to the increased protein turnover of MTA2 observed in DKO cells (Fig. 3A) .
Because the Sin3A and NuRD complexes appeared to be disrupted in DKO cells, we next investigated what effect this had on the levels of global histone acetylation using quantitative Western blotting. Pluripotent ES cells maintain a relatively plastic chromatin structure and consequently have a high basal level of histone acetylation (25) . The loss of HDAC1/2 therefore produced a relatively modest increase in acetylation levels at most sites of histone acetylation, with the notable exceptions of H3K14Ac and H3K56Ac, which were increased threefold and fourfold, respectively (Fig. 3D) . The fact that we detected an increase in the acetylation of all of the sites tested in histone H3 and H4 speaks to the pleiotropic nature of HDAC1/2 function. However, the levels H3K4me2 and H3K9me3, two methylation sites within the H3 tail that typify euchromatic and heterochromatic regions of the genome, remained largely unchanged.
HDAC1/2 Regulate the ES Cell Transcriptome and Are Required for
Expression of Oct4 and Nanog. HDAC1/2 have a well-described role in the regulation of gene expression (11) . Furthermore, the increase in global histone acetylation levels suggested that the pattern of gene expression may well be altered in Hdac1/2-deleted cells. We therefore performed a comparative microarray analysis on mRNA isolated from DKO cells at 0, 1, 2, and 3 days following Hdac1/2 inactivation, and transcripts deregulated ≥1.4-fold (adjusted P < 0.05) were identified from three independent Significance (P value) was calculated using a twotailed t test (*P < 0.01; **P < 0.001; ***P < 0.0001). Quantitative Western blotting was used to determine the levels of global histone acetylation. Acetylation levels were normalized to the total amount of H3 quantified using an Odyssey scanner. All values are means (n > 3) ± SEM. The significance (P value) of data in A, B, and D was calculated using a two-tailed t test (*P < 0.01; **P < 0.001).
experiments ( Fig. 4A and Dataset S1). Interestingly, we observed a correlation between the reduction in HDAC activity and the number of deregulated genes, with very few (n = 3) aberrantly expressed transcripts observed on day 1 and an increasing number on day 2 (560 genes) and day 3 (1,708 genes), as HDAC1/2 are progressively lost (Fig. 4B) . To further verify the microarray result, we quantified the levels of six down-regulated, seven up-regulated, and five unchanged transcripts by quantitative real-time PCR (qRT-PCR) (Fig. 4C) . In each instance (18 of 18 transcripts), we were able to corroborate the microarray result. An analysis of functionally related gene groups among deregulated genes using Database for Annotation, Visualization, and Integrated Discovery (DAVID) (30) , reveals that genes involved in cell death are up-regulated, whereas cell cycle genes are significantly down-regulated (Fig. 4D) , confirming the dominant phenotype observed in the DKO cells. Down-regulated transcripts are highly enriched for genes with a role in the regulation of transcription (P = 7.4 × 10 −14 ) and cell cycle processes (P = 4.88 × 10 ), as might be expected. However, genes involved in RNA processing are also decreased to the same level of significance (P = 8.4 × 10 −14 ), suggesting a putative role for HDAC1/2 in the regulation of RNA splicing. Significant to the self-renewal properties of ES cells, the pluripotent factor, Nanog, was down-regulated 1.81-fold on the array and 4.6-fold by qRT-PCR (Fig. 4C) . Furthermore, transcript levels of the pluripotent factors, Oct4 (Pou5f1), Rex1 (Zfp42), Esrrb,and Zfx, were also significantly reduced (between 1.45-and 1.63-fold; P < 0.005; Dataset S1). It is noteworthy that we also detected a distinct change in cell morphology of DKO cells at day 3, suggesting a loss of the stem cell phenotype (Fig. S2A) . This prompted us to analyze an additional 39 genes (80 probes) relating to transcripts for factors associated with pluripotency ( Fig. 4E and Table S1 ). We observed a progressive loss of pluripotent factor expression (R 2 = 0.96; P = 0.019) over the 3-day time period in which HDAC1/2 activity is lost. The protein levels of both Oct4 and Nanog were also reduced in parallel with the decrease of HDAC1/2 activity (Fig. 4F) . However, analysis of 111 genes (165 probes) associated with stem cell differentiation and lineage specification reveals only a weak positive correlation (R 2 = 0.66; P = 0.186). Recent bioinformatics analyses have uncovered the "PluriNet," a common set of characteristics shared by all pluripotent stem cell lines (31) . We therefore performed gene set enrichment analysis on PluriNet target genes to determine the consequence of Hdac1/2 DKO on maintaining ES cell identity. Of the 296 PluriNet genes, 90 were significantly enriched in wild-type control ES cells (Fig. S4) , demonstrating a loss of the pluripotent stem cell phenotype in DKO cells. Together, this suggests that HDAC1/2 are required for Oct4 and Nanog expression, but their loss is not sufficient to derepress genes associated with early differentiation.
Rescue of DKO Cells Is Dependent upon the Integrity of the HDAC1 IP 4 Binding Pocket. It seemed likely that the essential requirement for HDAC1/2 in cell division and their ability to influence gene expression was dependent upon deacetylase activity. To confirm this, we transfected DKO cells with cDNAs for wild type and a catalytically inactive version [HDAC1 Y303H (32) ] of HDAC1 to assess their ability to rescue cell viability (Fig. 5) . Although wildtype HDAC1 was able to rescue DKO cells, the majority of cells transfected with HDAC1
Y303H still died at day 4 following Hdac1/2 deletion. We therefore had an excellent model system in which to interrogate aspects of HDAC1 activity. It was recently (E) Regression analysis of pluripotency and differentiation associated genes using mean log 2 fold changes of microarray data. (F) Quantitative Western blot data for Oct4 and Nanog proteins indicate a reduction in parallel with the decrease of HDAC1/2 activity. Significance (P value) was calculated using a two-tailed t test (*P < 0.01).
shown, using in vitro assays, that HDAC1 activity is modulated by IP 4 (5). The IP 4 binding pocket on the surface of HDAC1 is made up of a number of positively charged residues (K31, R270, and R306), which are thought to form hydrogen bonds with the negatively charged phosphates of IP 4 (Fig. 5A ) and are required for IP 4 -dependent activation. To test the requirement for IP 4 binding to the activity of HDAC1 in cells, we mutated these three residues to glutamine, a polar noncharged residue, individually (K31Q, R270Q, R306Q), as double mutants (K31Q/ R270Q, R270Q/R306Q) and as a triple mutant (K31Q/R270Q/ R306Q). We transfected these constructs into DKO cells to initially test their expression and relative deacetylase activity (Fig. S5) . Mutation of each of the positively charged residues reduced the deacetylase activity of HDAC1, with combinations of mutations having an additive effect, such that the triple mutant (HDAC1 K31Q/R270Q/R306Q ) had the lowest activity of all. These same constructs were then tested for their ability to rescue the viability of Hdac1/2 DKO cells at 4 days following gene inactivation. Again, single-point mutations (K31Q, R270Q, and R306Q) produced a lower number of viable DKO cells compared with controls, whereas double and triple substitutions resulted in an additive effect, such that HDAC1 K31Q/R270Q/R306Q produced the smallest number of viable cells (Fig. 5B) . It is worth noting that the catalytically inactive HDAC1
Y303H always produced fewer viable cells in this assay than untransfected controls, indicating a dominant-negative effect of this mutation. HDAC1 K31Q/R270Q/R306Q appears to be a hypomorphic mutant, as it produces more viable DKO cells than HDAC1
Y303H , but far fewer than wild-type HDAC1. This implies that IP 4 binding is necessary for the full activity of HDAC1 in vivo.
Discussion
Essential and Pleiotropic Roles for HDAC1/2 in Cellular Proliferation.
We have generated a mouse ES cell line in which we can conditionally inactivate the highly related genes Hdac1 and Hdac2 simultaneously. Loss of HDAC1/2 results in a 60% reduction in cellular HDAC activity (Fig. 1C) despite a compensatory increase in the related class 1 HDAC, HDAC3 (Fig. 3B) . The increase in HDAC3 occurs at the protein level, because Hdac3 transcripts were not significantly altered in our microarray analysis ( Fig. 4A and Dataset S1). Interestingly, we observed a significant increase in DNA abnormalities with Hdac1-KO, Hdac1-KO; Hdac1-Het, and DKO cells, but not Hdac2-KO cells (Fig. 2C) . A comparison of the total HDAC activity for each of these cell lines revealed a significant reduction in all but the Hdac2-KO cells (Fig. S6) , suggesting that this phenotype is dependent on the dosage of HDAC1/2 activity. The predominant phenotype of Hdac1/2 DKO cells is a loss of viability 4 days after gene inactivation. The lethality is dependent on an active cell cycle, because if we first stimulate cell cycle exit, by generating embryoid bodies (Fig. 1F ) or using retinoic acid (Fig. S1B) , the majority of cells remained viable. A loss of cell proliferation is a common phenotype in all Hdac1/2 knockout (18, 23, 33, 34) and knockdown (35) studies. In each case, loss of HDAC1/2 is associated with up-regulation of the cyclin-dependent kinase inhibitor, p21 WAF1/CIP1 , which limits G 1 -to S-phase transition. Indeed, the proliferation of mammalian cells is largely controlled during the G 1 phase, therefore implicating HDAC1/2 activity in this critical step. However, ES cells have a peculiarly short G 1 phase (∼1.5 h), in which CDK2 complexes are constitutively active and Rb hyperphosphorylated (36, 37) , and therefore lack the usual G 1 restriction point of somatic cells. This presumably explains the difference in phenotype between DKO ES cells and other model systems, including mouse embryo fibroblasts (MEFs). Hdac1/2 KO MEFs undergo G 1 arrest, associated with increased expression of the aforementioned, p21
WAF1/CIP1 and p57
Kip2 (23) . Hdac1/2 KO ES cells lacking this G 1 regulatory step are unable to arrest in G 1 and therefore enter S phase, and later mitosis, where the absence of HDAC1/2 activity causes lethality. We detected a significant increase in both chromatin bridges, micronuclei ( Fig. 2B and Fig. S2C ), and a reduction in S-phase cells (Fig. S1C ) upon Hdac1/2 deletion, indicative of DNA replication defects. This is supported by data from Sirbu et al. (15), who used the iPOND technique to show that HDAC1/2 are present at active replication forks; and Bhaskara et al. (38) , who demonstrated that chemical inhibition or knockdown of HDAC1/2 reduced replication fork velocity and activates the replication stress response. In addition, we also observed that a high proportion of DKO cells in mitosis display abnormal spindles (Fig. 2) , which could equally lead to chromosome segregation errors. Deletion studies of other HDAC1/2 complex components, including SDS3 (16) and Sin3A (17) , suggest that HDAC1/2 maintain the hypoacetylated state of pericentric heterochromatin, a requirement for the appropriate assembly of the kinetochore. It is likely that a combination of DNA replication and mitotic defects are the major cause of death in cells lacking HDAC1/2.
HDAC1/2 Regulate the Expression of Core Pluripotency Factors in ES
Cells. Loss of HDAC1/2 activity correlates with the down-regulation of pluripotent factors (Fig. 4 E and F) . Interestingly, this phenotype contrasts with the disruption of individual HDAC1/2-containing complexes in ES cells. Deletion of LSD1 perturbs the CoREST complex but does not affect Oct4 expression (39) , whereas loss of MBD3 (central component of NuRD) prevents Oct4 from being repressed at all, even under differentiating conditions (40) . By process of elimination, this suggests that the Sin3A complex may positively regulate Oct4 and Nanog expression; and indeed Baltus et al. (41) were able to demonstrate a direct role for the Sin3A/HDAC complex in the activation of the Nanog promoter. More recently, a genome-wide promoter analysis in ES cells revealed that HDAC1 binds close to the transcriptional start site of many pluripotent factors, including Oct4, Nanog, Sox2, and Rex1 (7), again suggesting a positive role in the maintenance of cell self-renewal. These data, and complementary genome-wide ChIP studies that reveal an enrichment of HDAC1 binding at active gene loci (8, 42) , are beginning to change the view of HDAC1/2 from being exclusively repressive factors, to regulators of both gene activation and repression.
Although it was previously thought that HDAC complexes are constitutively active, it was recently shown that the deacetylase activity of HDAC1 and HDAC3 is regulated through binding of an IP 4 molecule sandwiched between the HDAC and its cognate corepressor (5, 43) . This raises the important question of whether IP 4 actually regulates HDAC activity in vivo. We have shown here for the first time (to our knowledge) that substitution of the positively charged residues in the IP 4 binding pocket of HDAC1 (K31Q, R270Q, and R306Q), essential for IP 4 binding Significance (P value) was calculated using a two-tailed t test.
(5), reduces the activity of HDAC1 and its ability to rescue the viability of DKO cells (Fig. 5) . The HDAC1 triple mutant, HDAC1 K31Q/R270Q/R306Q , reduces the number of viable DKO cells by approximately threefold, which is in agreement with a previous study that showed that an HDAC1:MTA1 complex could be stimulated threefold to fourfold by addition of IP 4 .
In summary, we have shown that loss of HDAC1/2 activity in ES cells leads to the deregulation of almost 2,000 genes, including down-regulation of the core pluripotent factors, Oct4 and Nanog. Using these DKO cells as a model system to measure HDAC1/2 activity, we have shown for the first time (to our knowledge) that mutations that abolish IP 4 binding reduce the activity of HDAC1 in vivo and, finally, that Hdac1/2 inactivation resulted in a loss of ES cell viability. Our data also suggest that inactivation of HDAC1/2, in cells that either lack (ES cells) or have a mutated G 1 restriction checkpoint (cancer cells), causes cell death due to defective DNA replication and/or mitosis. This leads us to predict that specific inhibitors of HDAC1/2 should exhibit selective toxicity toward immortalized cell types, making them effective therapeutic targets in the treatment of cancer. ; CreER ES clones were used in the study.
ES Cell Culture and Differentiation. ES cell lines were maintained on gelatinized plates in standard ES cell medium as previously described (25) . To induce Hdac1/2 deletion, cells were cultured for 24 h in the presence of OHT (1 μM) to activate the CreER fusion protein. For ES cell growth curves, control and Hdac1/2 knockout ES cells were plated at 3 × 10 5 ES cells per well in a sixwell plate, and viable cells were counted on 4 consecutive days. ES cells were differentiated by embryoid body formation in suspension culture, or using RA (1 μM) on gelatinized plates. All cells were counted using Bio-Rad TC-10 automated cell counter in triplicate. For more details, and a complete list of antibodies and qRT-PCR primers used in this study (Tables S2 and S3 ), see SI Methods.
